Q92.0 Whole chromosome trisomy, nonmosaicism (meiotic nondisjunction)

Name of the Condition

• Whole chromosome trisomy, nonmosaicism (meiotic nondisjunction)

Summary

Whole chromosome trisomy, nonmosaicism (meiotic nondisjunction) is a chromosomal abnormality where an extra copy of an entire chromosome is present in all cells due to a failure of chromosomes to separate properly during meiosis. This results in a total of 47 chromosomes instead of the typical 46. The condition is typically identified through genetic testing and may lead to developmental and physical abnormalities depending on the chromosome involved.

Causes

This condition is caused by meiotic nondisjunction, a process where chromosomes fail to separate correctly during the formation of reproductive cells (gametes). This error can occur in either the egg or sperm, leading to an embryo with an extra chromosome. While the exact reasons for nondisjunction are not always clear, it is often a random event without a specific identifiable cause.

Risk Factors

• Advanced maternal age, as the risk of meiotic nondisjunction increases with age.
• A history of previous pregnancies with chromosomal abnormalities.
• Certain genetic predispositions that may affect chromosome segregation.

Symptoms

• Developmental delays, including cognitive and motor impairments.
• Distinctive physical features, such as facial dysmorphisms or growth abnormalities.
• Organ system abnormalities, depending on the specific chromosome involved (e.g., heart defects, kidney issues).

Diagnosis

Diagnosis is typically made through prenatal or postnatal genetic testing, such as karyotyping or chromosomal microarray analysis. Prenatal screening may include ultrasound findings suggestive of chromosomal abnormalities, followed by confirmatory testing. Postnatal diagnosis involves analyzing a blood sample to identify the extra chromosome.

Treatment Options

Treatment focuses on managing symptoms and associated conditions. This may include early intervention services for developmental delays, surgical corrections for physical abnormalities, and ongoing medical care for organ system issues. Supportive therapies, such as physical or occupational therapy, are often recommended.

Prognosis and Follow-Up

Prognosis varies widely depending on the specific chromosome involved and the severity of associated abnormalities. Some trisomies are incompatible with life, while others allow for survival with varying degrees of disability. Regular follow-up with a multidisciplinary team, including geneticists, pediatricians, and specialists, is essential to monitor development and address complications.

Complications

• Increased risk of congenital heart defects.
• Higher susceptibility to infections due to immune system abnormalities.
• Gastrointestinal or renal abnormalities.
• Neurological impairments, including seizures or intellectual disability.

Lifestyle & Prevention

While the condition is typically not preventable, prenatal care and genetic counseling may help assess risks. Folic acid supplementation before and during pregnancy is recommended to support overall fetal development, though it does not specifically prevent chromosomal nondisjunction.

When to Seek Professional Help

Seek medical attention if prenatal screening suggests a chromosomal abnormality or if a newborn exhibits developmental delays, physical abnormalities, or organ system issues. Early diagnosis and intervention can improve outcomes.

Tips for Medical Coders

Document the specific chromosome involved (e.g., trisomy 21, trisomy 18) when available, as this may impact coding specificity. Ensure the diagnosis is supported by genetic testing results, and note whether the condition is confirmed prenatally or postnatally. Use this code for nonmosaic whole chromosome trisomy due to meiotic nondisjunction; do not use it for mosaicism or other chromosomal abnormalities.